Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation
Clinical trial NCT01474551 · TERMINATED
Trial details
- NCT number
- NCT01474551
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-03-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.